Enzyme replacement therapy for Fabry disease: lessons from two α-galactosidase A orphan products and one FDA approval

By Desnick Robert J  

Expert Opinion on Biological Therapy, Vol. 4, Iss. 7, 2004-07 ,pp. : 1167-1176

Informa Healthcare

Access to resources Recommend Favorite

The Carboxyl Terminus of Coffee Bean α-Galactosidase Is Critical for Enzyme Activity

By Maranville E.   Zhu A.  

Archives of Biochemistry and Biophysics, Vol. 373, Iss. 1, 2000-01 ,pp. : 225-230

Elsevier

Access to resources Recommend Favorite

Production in yeast of α -galactosidase A, a lysosomal enzyme applicable to enzyme replacement therapy for Fabry disease

By Chiba Yasunori  

Glycobiology, Vol. 12, Iss. 12, 2002-12 ,pp. : 821-828

Oxford University Press

Access to resources Recommend Favorite

Human α-galactosidase A: characterization of the N -linked oligosaccharides on the intracellular and secreted glycoforms overexpressed by Chinese hamster ovary cells

By Ioannou Y.A.  

Glycobiology, Vol. 8, Iss. 4, 1998-04 ,pp. : 329-341

Oxford University Press

Access to resources Recommend Favorite

Purification and Characterization of Human α-Galactosidase A Expressed in Insect Cells Using a Baculovirus Vector

By Chen Y.   Jin M.   Goodrich L.   Smith G.   Coppola G.   Calhoun D.H.  

Protein Expression and Purification, Vol. 20, Iss. 2, 2000-11 ,pp. : 228-236

Academic Press

Access to resources Recommend Favorite